entertainment -WSS

entertainment

author：knowledge 2025-10-01 22:39:16 - browse：97934

Drew Weissman (left) and Katalin Karikó (right) — Drew Weissman (left) and Katalin Karikó, whose longtime partnership was recognized with a Nobel Prize on Monday. Peggy Peterson/Penn Medicine

The most noteworthy aspect of awarding the Nobel Prize in medicine or physiology to two pioneers of mRNA research was not who won Monday — Katalin Karikó and Drew Weissman were widely expected to get the accolade for discoveries that made it possible to deliver the finicky molecule to cells and enabled the record-breaking development of vaccines that tamed the Covid-19 pandemic. It was the way the two scientists worked together.

The Nobel committee framed Karikó and Weissman’s work as a prime example of complementary expertise, with Karikó focused on RNA-based therapies and Weissman bringing a deep knowledge about immune responses to vaccines. In a rare moment for science’s top honor, which elevates the individual contributions of one, two, or at most, three researchers to a particularly impactful breakthrough, it is a celebration of a true scientific partnership — a durable and fruitful collaboration spanning more than two decades of working shoulder-to-shoulder at the lab bench that turned a scientific backwater into a blockbuster technology.

“We couldn’t get funding, we couldn’t get publications, we couldn’t get people to notice mRNA as something interesting,” Weissman told reporters at a press conference Monday at the University of Pennsylvania. “But Kati lit the match and we spent the rest of the next 20 plus years working together figuring out how to get it to work. We would sit together in 1997 and afterwards and talk about all the things we thought RNA could do. And that’s why we never gave up,” he said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

WSS

Diagnostic tests are hitting their mathematical limits

FTX founder Sam Bankman

Takeda, Janssen join wearable maker to measure scratching

Sage's campaign to raise awareness of postpartum depression hits a nerve

Travel bans should be based on evidence, not politics or fear

Despite FDA concern, risk that CAR

explore

entertainment

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

J&J to emphasize cancer drugs, stop much of its vaccine research

Apple is now the first public company to be valued at $3 trillion

Biden praises World Series champion Astros for impact off the field during White House celebration

Affirmative action in medical school literally saved lives

Wegovy cuts risk of cardiovascular events by 20%, study finds

Hepatitis C has a cure — but many Americans still lack access to it

J&J to emphasize cancer drugs, stop much of its vaccine research

ChatGPT in medicine: STAT answers readers' burning questions

CDC director unscathed in first congressional testimony

knowledge

Discs beat pads, tampons for heavy menstrual flow, new study shows

Travel bans should be based on evidence, not politics or fear

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

The painfully weak evidence on taking collagen to treat arthritis

Wegovy cuts risk of cardiovascular events by 20%, study finds

Biden praises World Series champion Astros for impact off the field during White House celebration

Wikipedia

Wikipedia

focus

entertainment